FDG-PET扫描在心律失常性心肌炎中的临床应用
该研究纳入75例心律失常性心肌炎患者行FDG-PET扫描,以心内膜心肌活检和心脏磁共振为参考标准,发现FDG-PET诊断敏感度分别为75%和73%,特异度分别为67%和59%;前间隔FDG分布与更差心律失常结局相关,重复FDG-PET可指导免疫抑制撤除。
要点
- FDG-PET在CMR不适用时(心律不齐或ICD伪影)可作为诊断心律失常性心肌炎的补充手段。
- 前间隔FDG分布提示心脏结节病可能,且与室性心律失常和房室传导阻滞风险增高相关。
- 重复FDG-PET可在随访中监测心肌炎活动性,指导免疫抑制治疗的撤除。
核心结论
- FDG-PET扫描可能是心律失常性心肌炎有用的诊断技术,尤其当CMR因心律不齐或ICD相关伪影而不适用时。
- 前间隔FDG分布与更差的心律失常结局相关,应提高对心脏结节病的怀疑。
- 随访中重复FDG-PET可监测心肌炎以指导免疫抑制撤除。
研究设计与样本
- 单中心研究纳入75例连续患者(年龄47±14岁,65%男性),因心律失常性心肌炎行FDG-PET扫描。
- 心肌炎诊断依据心内膜心肌活检(EMB)及适当时的心脏磁共振(CMR)。
- FDG-PET指征包括CMR禁忌(n=50)或CMR与EMB不匹配(n=25)。
关键影像表现/征象
- 50例(67%)患者FDG-PET阳性。
- 前间隔分布模式见于50例中12例(24%),包括7例心脏结节病全部7例。
诊断标准与关键数值
- 以EMB为参考,FDG-PET诊断敏感度75%,特异度67%。
- 以CMR为参考,FDG-PET诊断敏感度73%,特异度59%。
- 在边缘性心肌炎、晚期(>30天)或免疫抑制状态下行FDG-PET扫描时,FDG-PET准确性较低。
- 前间隔分布患者随访4.2±1.7年中室性心律失常发生10/12 vs 7/38,房室传导阻滞7/12 vs 0/38(均P<0.001)。
- 39例(52%)患者在13±2个月重复FDG-PET,首次(76%)或第二次(24%)复查FDG摄取正常化后允许撤除免疫抑制。
临床应用与阅片要点
- 当CMR因心律不齐或ICD伪影不可用时,可考虑FDG-PET辅助诊断心律失常性心肌炎。
- 阅片时注意前间隔FDG分布,应提示心脏结节病可能并关注心律失常风险。
- 随访中重复FDG-PET可用于监测心肌炎活动性,指导免疫抑制撤除决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) scan has no recognized role in diagnosis, prognosis, and disease monitoring in patients with arrhythmic myocarditis.
OBJECTIVES: The purpose of this study was to investigate the value of FDG-PET scan in arrhythmic myocarditis.
METHODS: The authors enrolled 75 consecutive patients (age 47 ± 14 years, 65% men) undergoing FDG-PET scan for arrhythmic myocarditis. Myocarditis was diagnosed by endomyocardial biopsy (EMB) and, whenever applicable, cardiac magnetic resonance (CMR).
RESULTS: Indications for FDG-PET scan included either contraindication to CMR (n = 50) or mismatch between CMR and EMB (n = 25). Overall, 50 patients (67%) had positive FDG-PET. Sensitivity was 75% referring to EMB, and 73% to CMR. Specificity was 67% referring to EMB, and 59% to CMR. FDG-PET accuracy was lower in the presence of borderline myocarditis, and either late (>30 days) or on-immunosuppression FDG-PET scanning. Anteroseptal distribution pattern, found in 12 of 50 (24%) patients including 7 of 7 cardiac sarcoidosis cases, was associated with greater occurrence of ventricular arrhythmias and atrioventricular blocks in 4.2 ± 1.7 years of follow-up (10 of 12 vs 7 of 38, and 7 of 12 vs 0 of 38, respectively; both P < 0.001). In 39 patients (52%), FDG-PET was repeated by 13 ± 2 months, allowing immunosuppression withdrawal after FDG uptake normalization either by first (76%) or second reassessment (24%).
CONCLUSIONS: FDG-PET scan may be a clinically useful diagnostic technique in arrhythmic myocarditis, in particular when CMR is unsuitable because of irregular heartbeat or implantable cardioverter-defibrillator-related artifacts. Anteroseptal FDG distribution is associated with a worse arrhythmic outcome and should raise the suspicion of cardiac sarcoidosis. During follow-up, repeated FDG-PET allows myocarditis monitoring to guide immunosuppression withdrawal.
引用
- Peretto, Busnardo, Ferro, et al. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis. JACC Cardiovasc Imaging. 2022. PMID: 36202457. doi:10.1016/j.jcmg.2022.02.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。